Peter S. Hoffmeister MD
Assistant Professor, Medicine
150 S Huntington Avenue | (617) 638-5300peter.hoffmeister@va.gov
Biography
Dr. Peter Hoffmeister is a cardiologist in Burlington, Massachusetts and is affiliated with multiple hospitals in the area, including Brigham and Women's Hospital and Veterans Affairs Boston Healthcare System-West Roxbury. He received his medical degree from Albany Medical College and has been in practice between 11-20 years.
Education
MD, Albany Medical College
BS, Rensselaer Polytechnic Institute
Publications
Okazaki RA, Flashner LC, Kinlay S, Peralta AO, Hoffmeister PS, Yarmohammadi H, Joseph J, Yuyun MF. Catheter ablation for atrial fibrillation in patients with significant mitral regurgitation: A systematic review and meta-analysis. Heart Rhythm. 2024 Jul 31. PMID: 39094723.
Published on 7/2/2024Yuyun MF, Joseph J, Erqou SA, Kinlay S, Echouffo-Tcheugui JB, Peralta AO, Hoffmeister PS, Boden WE, Yarmohammadi H, Martin DT, Singh JP. Evolution and prognosis of tricuspid and mitral regurgitation following cardiac implantable electronic devices: a systematic review and meta-analysis. Europace. 2024 Jul 02; 26(7). PMID: 38812433.
Published on 2/13/2024Kroshian G, Joseph J, Kinlay S, Peralta AO, Hoffmeister PS, Singh JP, Yuyun MF. Atrial fibrillation and risk of adverse outcomes in heart failure with reduced, mildly reduced, and preserved ejection fraction: A systematic review and meta-analysis. J Cardiovasc Electrophysiol. 2024 Apr; 35(4):715-726. PMID: 38348517.
Published on 10/19/2023Yuyun MF, Joseph J, Erqou SA, Kinlay S, Echouffo-Tcheugui JB, Peralta AO, Hoffmeister PS, Boden WE, Yarmohammadi H, Martin DT, Singh JP. Persistence of significant secondary mitral regurgitation post-cardiac resynchronization therapy and survival: a systematic review and meta-analysis : Mitral regurgitation and mortality post-CRT. Heart Fail Rev. 2024 Jan; 29(1):165-178. PMID: 37855988.
Published on 8/6/2021Yuyun MF, Erqou SA, Peralta AO, Hoffmeister PS, Yarmohammadi H, Echouffo Tcheugui JB, Martin DT, Joseph J, Singh JP. Risk of ventricular arrhythmia in cardiac resynchronization therapy responders and super-responders: a systematic review and meta-analysis. Europace. 2021 08 06; 23(8):1262-1274. PMID: 33496319.
Published on 2/6/2021Yuyun MF, Erqou SA, Peralta AO, Hoffmeister PS, Yarmohammadi H, Echouffo-Tcheugui JB, Martin DT, Joseph J, Singh JP. Ongoing Risk of Ventricular Arrhythmias and All-Cause Mortality at Implantable Cardioverter Defibrillator Generator Change: A Systematic Review and Meta-Analysis. Circ Arrhythm Electrophysiol. 2021 03; 14(3):e009139. PMID: 33554611.
Published on 5/12/2018Ofman P, Hoffmeister P, Kaloupek DG, Gagnon DR, Peralta A, Djousse L, Gaziano JM, Rahilly-Tierney CR. Posttraumatic stress disorder and mortality in VA patients with implantable cardioverter-defibrillators. Clin Cardiol. 2018 May; 41(5):652-659. PMID: 29532498.
Published on 6/30/2014Ofman P, Petrone AB, Peralta A, Hoffmeister P, Albert CM, Djousse L, Gaziano JM, Rahilly-Tierney CR. Aspirin use and risk of atrial fibrillation in the Physicians' Health Study. J Am Heart Assoc. 2014 Jun 30; 3(4). PMID: 24980132.
Published on 6/30/2013Ofman P, Peralta A, Hoffmeister P, Gaziano JM, Djousse L. Do Omega-3 Fatty Acids Decrease the Incidence of Atrial Fibrillation? J Atr Fibrillation. 2013 Jun-Jul; 6(1):836. PMID: 28496856.
Published on 3/20/2013Ofman P, Khawaja O, Rahilly-Tierney CR, Peralta A, Hoffmeister P, Reynolds MR, Gaziano JM, Djousse L. Regular physical activity and risk of atrial fibrillation: a systematic review and meta-analysis. Circ Arrhythm Electrophysiol. 2013 Apr; 6(2):252-6. PMID: 23515264.